Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Augusto Akikubo Rodrigues Pereira"'
Autor:
Augusto Akikubo Rodrigues Pereira, Vanessa Alves Silva, Luciana Menezes Mendonca Ocea, Natalia Breve Mingues, Aldo Lourenço Abbade Dettino, Juliana Valim Romero, Milena Shizue Tariki, Jose Luiz Gasparini Junior, Emne Ali Abdallah, Ludmilla Thomé Domingos Chinen, Marcello Ferretti Fanelli
Publikováno v:
Journal of Clinical Oncology. 32:e22020-e22020
e22020 Background: The presence of circulating tumor cells (CTCs) is a necessary process for cancer progression. In fact, its detection has surged as a potential biomarker for clinical response in ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::532737aa9e0604e8ea23826c54bf2090
https://doi.org/10.1200/jco.2014.32.15_suppl.e22020
https://doi.org/10.1200/jco.2014.32.15_suppl.e22020
Autor:
Fernanda Navarro Loiola, Marcos Pedro Guedes Camandaroba, Augusto Akikubo Rodrigues Pereira, Viviane Teodoro Oliveira Fernandes
Publikováno v:
Journal of Clinical Oncology. 32:e15122-e15122
e15122 Background: Currently, there is no standard treatment after progression in the first-line therapy with gemcitabine-based regimens for pancreatic and biliary tract carcinomas. Methods: We ret...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a271a8e44ab30415f40453df372130f
https://doi.org/10.1200/jco.2014.32.15_suppl.e15122
https://doi.org/10.1200/jco.2014.32.15_suppl.e15122
Autor:
Celso Lopes Mello, Aldo Lourenço Abbade Dettino, Tiago Felismino, Nirvana Formiga, Victor Hugo Fonseca de Jesus, Helano C. Freitas, Charles Edouard Zurstrassen, Augusto Akikubo Rodrigues Pereira, Ulisses Ribaldo Nicolau
Publikováno v:
Journal of Clinical Oncology. 32:e21520-e21520
e21520 Background: TACE local palliative therapy has been increasingly employed in clinical practice for managing patients (pts) harboring chemotherapy (CT) refractory RMAMT. Relief of symptoms, e....
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfd2732451a0b79679206d0a0d87b4ed
https://doi.org/10.1200/jco.2014.32.15_suppl.e21520
https://doi.org/10.1200/jco.2014.32.15_suppl.e21520
Autor:
Ronnei J F Assis, Vladmir Cláudio Cordeiro de Lima, Augusto Akikubo Rodrigues Pereira, Pedro B. Nugue, José Rodrigues Pereira, Emiliano Pereira
Publikováno v:
Journal of Clinical Oncology. 31:e18548-e18548
e18548 Background: The standard first-line treatment for extensive-stage small-cell lung cancer (ES-SCLC) has been cisplatin plus etoposide (PE). Phase II studies showed comparable outcomes and less toxicity with platinum-doublets containing gemcitab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c2c2f7f5f8ba7bd37c49d32e10f5286
https://doi.org/10.1200/jco.2013.31.15_suppl.e18548
https://doi.org/10.1200/jco.2013.31.15_suppl.e18548
Autor:
Renato Pierre, André Lopes Carvalho, Carlos Roberto dos Santos, Antonio Cassio Assis Pellizzon, Luiz Paulo Kowalski, Ulisses Ribaldo Nicolau, Thiago de Oliveira Bueno, Ricardo Lincoln, Augusto Akikubo Rodrigues Pereira, Marcos Duarte, Luciano de Souza Viana, Olavo Feher, Rosane Oliveira Sant'Ana
Publikováno v:
Oral Oncology. 49:S22
Background Since the results of the RTOG 9111 trial, cisplatin-based chemoradiation (CRT) has been the standard of care forLPin advanced laryngeal SCC. Recently, the role of taxanes in managing locally advanced head and neck SCC has been studied. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ff63301bce7a6f52b97dbb36cdfbb2a
https://doi.org/10.1016/j.oraloncology.2013.03.052
https://doi.org/10.1016/j.oraloncology.2013.03.052
Autor:
Joyce Maria L. Maia, Flávio Augusto Ismael, Adriana Regina Gonçalves Ribeiro, Ludmilla Thomé Domingos Chinen, Augusto Akikubo Rodrigues Pereira, Tadeu Ferreira Paiva Júnior, Celso Lopes Mello, Milton Jose De Barros E. Silva, Fernando Vidigal Padua, Elizabeth Santana dos Santos, Daniel Campanha, Marcello Ferretti Fanelli
Publikováno v:
Annals of Oncology. 23:iv65
Introduction Despite the lack of high-quality clinical trial data suggesting that second-line chemotherapy (SLC) may affect survival on metastatic pancreatic cancer (mPC), most of centers utilizes them after the failure of initial treatment in patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c8ef7f98e529db8451f052c19f96231
https://doi.org/10.1016/s0923-7534(20)30038-7
https://doi.org/10.1016/s0923-7534(20)30038-7
Autor:
Augusto Akikubo Rodrigues Pereira, Flavio Augusto Ismael Pinto, Joyce Maria L. Maia, Celso Lopes Mello, Adriana Regina Gonçalves Ribeiro, Milton Jose De Barros E. Silva, Fernando Vidigal Padua, Daniel Campanha, Marcello Ferretti Fanelli, Tadeu Ferreira Paiva, Elizabeth Santana dos Santos, Ludmilla Thomé Domingos Chinen
Publikováno v:
Journal of Clinical Oncology. 30:e14680-e14680
e14680 Background: Despite the lack of high-quality clinical trial data suggesting that second-line chemotherapy (SLC) may affect survival on metastatic pancreatic cancer (mPC), most of centers utilizes them after the failure of initial treatment in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25355cda3c8de6ff1a28eb57f610011a
https://doi.org/10.1200/jco.2012.30.15_suppl.e14680
https://doi.org/10.1200/jco.2012.30.15_suppl.e14680
Autor:
Vladmir Cláudio Cordeiro de Lima, Rafael Costa Lessa, José Augusto Rinck, Sandro José Martins, Marcello Ferretti Fanelli, Augusto Akikubo Rodrigues Pereira, Fernando Vidigal de Pádua, Flavio Augusto Ismael Pinto, Debora de Melo Gagliato, Geraldine Eltz Lima, Marcelo Rocha Cruz, José Rodrigues Pereira, Marclesson S. Alves, Ulisses Ribaldo Nicolau, Paulo Henrique Aires Freitas, Elizabeth Santana dos Santos, Aldo Lourenço Abbade Dettino, Newton Augusto Ferreira Rodrigues
Publikováno v:
Web of Science
e18078 Background: First-line treatment of advanced nonsquamous non-small cell lung cancer (NSCLC) with platinum-based doublets, including pemetrexed (P) or bevacizumab (B), has achieved more than 12 months of survival. At the moment, there are no ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76da087707a7b63f4702db2627f6d7f3
https://doi.org/10.1200/jco.2012.30.15_suppl.e18078
https://doi.org/10.1200/jco.2012.30.15_suppl.e18078
Autor:
José Rodrigues Pereira, José Augusto Rinck, Elizabeth Santana dos Santos, C. E. P. Souza, Aldo Lourenço Abbade Dettino, Ludmilla Thomé Domingos Chinen, V. C. C. de Lima, M. F. Fanelli, Ulisses Ribaldo Nicolau, Rafael Costa Lessa, Debora de Melo Gagliato, Marcelo Rocha Cruz, Augusto Akikubo Rodrigues Pereira, Flavio Augusto Ismael Pinto
Publikováno v:
Journal of Clinical Oncology. 29:e18067-e18067
e18067 Background: The combination of pemetrexed plus cisplatin (PC) was recently approved in the initial treatment of advanced stage non-small cell lung cancer (NSCLC). Studies reported comparable...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ebc673c20099155b49980370f89591b
https://doi.org/10.1200/jco.2011.29.15_suppl.e18067
https://doi.org/10.1200/jco.2011.29.15_suppl.e18067
Autor:
Heber Salvador de Castro Ribeiro, Marcello Ferretti Fanelli, Fernando Vidigal Padua, Augusto Akikubo Rodrigues Pereira, Joyce Maria L. Maia, Celso Lopes Mello, Adriana Regina Gonçalves Ribeiro, Maria Dirlei Begnami, Felipe José Fernandez Coimbra, Milton Jose De Barros E. Silva, Alessandro L. Diniz, Wilson Luiz da Costa, Maria Nirvana Formiga, Aldo Lourenço Abbade Dettino
Publikováno v:
Web of Science
e14728 Background: Ampullary cancer (AC) is a rare malignancy. There is no consensus about the role of adjuvant radiotherapy and chemotherapy, mainly for early-stage tumors. Methods: Between 2007 and 2012 we performed a retrospective analysis of pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a500ef192fed83e2693ae6c1dceaadd9
https://publons.com/wos-op/publon/12383497/
https://publons.com/wos-op/publon/12383497/
